MetLife, Inc. (MET) Financials
MET Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 687.6 billion | 657.3 billion |
| 2023-09-30 | 652.1 billion | 626.2 billion |
| 2023-06-30 | 677.3 billion | 646.8 billion |
| 2023-03-31 | 674.3 billion | 641.8 billion |
MET Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 4.8 billion | ? |
| 2023-09-30 | 3.5 billion | ? |
| 2023-06-30 | 3.8 billion | ? |
| 2023-03-31 | 2.0 billion | ? |
MET Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 607.0 million |
| 2023-09-30 | 489.0 million |
| 2023-06-30 | 402.0 million |
| 2023-03-31 | 80.0 million |
MET Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 308.1 billion | - | 32.0 million |
| 2023-09-30 | 292.4 billion | 18.6 billion | - |
| 2023-06-30 | 306.2 billion | 3.8 billion | - |
| 2023-03-31 | 306.5 billion | 3.9 billion | - |
MET Shares Outstanding
MET Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 383.0 million | - | 1.7 billion | - |
| 2023-09-30 | 423.0 million | - | 1.5 billion | - |
| 2023-06-30 | 774.0 million | - | 1.5 billion | - |
| 2023-03-31 | - | - | 1.5 billion | - |
MET Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 19.0 billion | - |
| 2023-09-30 | 15.9 billion | - |
| 2023-06-30 | 16.6 billion | - |
| 2023-03-31 | 15.4 billion | - |
MET
List: Contenders
Price: $72.72
Dividend Yield: 0.03%
Forward Dividend Yield: 2.88%
Payout Ratio: 114.92%
Dividend Per Share: 2.08 USD
Earnings Per Share: 1.82 USD
P/E Ratio: 36.36
Exchange: NYQ
Sector: Financial Services
Industry: Insurance - Life
Volume: 2.2 million
Ebitda: 817.5 millionMarket Capitalization: 53.2 billion
Average Dividend Frequency: 2
Years Paying Dividends: 25
DGR3: 4.35%
DGR5: 5.77%
DGR10: 9.50%
DGR20: 14.07%